Shares of Circassia Pharmaceuticals PLC (LON:CIR) hit a new 52-week low on Friday . The company traded as low as GBX 33 ($0.43) and last traded at GBX 33.30 ($0.44), with a volume of 203053 shares. The stock had previously closed at GBX 35 ($0.46).
A number of analysts have weighed in on the stock. Peel Hunt reissued a “buy” rating on shares of Circassia Pharmaceuticals in a report on Thursday, December 6th. Royal Bank of Canada dropped their price objective on shares of Circassia Pharmaceuticals from GBX 81 ($1.06) to GBX 65 ($0.85) and set a “sector performer” rating on the stock in a report on Thursday, January 24th.
COPYRIGHT VIOLATION WARNING: “Circassia Pharmaceuticals (CIR) Hits New 1-Year Low at $33.00” was first posted by Transcript Daily and is owned by of Transcript Daily. If you are accessing this news story on another site, it was illegally copied and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this news story can be read at https://transcriptdaily.com/2019/03/01/circassia-pharmaceuticals-cir-hits-new-1-year-low-at-33-00.html.
Circassia Pharmaceuticals Company Profile (LON:CIR)
Circassia Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of respiratory diseases. The company markets NIOX and NIOX VERO for use in asthma diagnosis and management; and Tudorza for the treatment of chronic obstructive pulmonary disease (COPD).
Featured Story: Penny Stocks, Risk and Reward Factors
Receive News & Ratings for Circassia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Circassia Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.